Explore
Validate
LearnM00283
antibody from Boster Biological Technology
Targeting: NFKB1
KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- M00283 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-NF-Kappa B (p105/p50) NFKB1 Rabbit Monoclonal Antibody
- Antibody type
- Monoclonal
- Description
- Monoclonal antibody for P50/NFKB1 detection. Host: Rabbit.Size: 100ug/vial. Tested applications: IHC, WB. Reactive species: Human, Mouse, Rat P50/NFKB1 information: Molecular Weight: 105356 MW; Subcellular Localization: Nucleus. Cytoplasm. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Antibody clone number
- ID-14
- Vial size
- 100ug/vial
- Concentration
- 0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure.
- Storage
- Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
Submitted references Gut microbiota contribution to selenium deficiency-induced gut-liver inflammation.
Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells.
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.
Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway.
Treatment with MQA, a Derivative of Caffeoylquinic Acid, Provides Neuroprotective Effects against Cerebral Ischemia Through Suppression of the p38 Pathway and Oxidative Stress in Rats.
Blockage of High-Affinity Choline Transporter Increases Visceral Hypersensitivity in Rats with Chronic Stress.
HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy.
Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Wang G, Jiang Z, Song Y, Xing Y, He S, Boomi P
BioFactors (Oxford, England) 2024 Mar-Apr;50(2):311-325
BioFactors (Oxford, England) 2024 Mar-Apr;50(2):311-325
Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells.
Önay Uçar E, Şengelen A, Mertoğlu Kamalı E
Biochemical pharmacology 2023 Feb;208:115409
Biochemical pharmacology 2023 Feb;208:115409
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.
Ye J, Deng W, Zhong Y, Liu H, Guo B, Qin Z, Li P, Zhong X, Wang L
International journal of oncology 2022 Aug;61(2)
International journal of oncology 2022 Aug;61(2)
Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway.
Fan SH, Xiong QF, Wang L, Zhang LH, Shi YW
Molecular and cellular endocrinology 2020 Dec 1;518:111005
Molecular and cellular endocrinology 2020 Dec 1;518:111005
Treatment with MQA, a Derivative of Caffeoylquinic Acid, Provides Neuroprotective Effects against Cerebral Ischemia Through Suppression of the p38 Pathway and Oxidative Stress in Rats.
Chen L, Liu DN, Wang Y, Liu XY, Han S, Zhang K, Li GY, Tian X, Wang HY, Wang JH
Journal of molecular neuroscience : MN 2019 Apr;67(4):604-612
Journal of molecular neuroscience : MN 2019 Apr;67(4):604-612
Blockage of High-Affinity Choline Transporter Increases Visceral Hypersensitivity in Rats with Chronic Stress.
Zhao C, Lin M, Pan Y, Yu B
Gastroenterology research and practice 2018;2018:9252984
Gastroenterology research and practice 2018;2018:9252984
HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy.
Zhao SQ, Xue ZZ, Wang LZ
Experimental and therapeutic medicine 2017 Dec;14(6):6138-6146
Experimental and therapeutic medicine 2017 Dec;14(6):6138-6146
Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Huang KF, Huang XP, Xiao GQ, Yang HY, Lin JS, Diao Y
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 May;68(4):455-61
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 May;68(4):455-61
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of paraffin-embedded human kidney, using NF-κB (p105/p50) Antibody.
- Additional image
